GE HealthCare TechnologiesGEHC +1.26%72 EV-to-FCF is 25.32 as of Jun. 28, 2026, which is 5% below its 10-year median of 26.73. GuruFocus rates GEHC with a GF Score™ of 72/100 and a GF Value™ of $85.04 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 419 Medical Devices & Instruments companies, GE HealthCare Technologies ranks worse than 54.65% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, GE HealthCare Technologies's Enterprise Value is $38,460 Mil.
GE HealthCare Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $1,519 Mil. Therefore, GE HealthCare Technologies's EV-to-FCF for today is 25.32.
The historical rank and industry rank for GE HealthCare Technologies's EV-to-FCF or its related term are showing as below:
GEHC'
s EV-to-FCF Range Over the Past 10 Years
Min: 18.96 Med: 26.73 Max: 34.63
Current: 25.32
During the past 7 years, the highest EV-to-FCF of GE HealthCare Technologies was 34.63. The lowest was 18.96. And the median was 26.73.
GEHC's EV-to-FCF is ranked worse than 54.65% of 419
companies
in the Medical Devices & Instruments industry
Industry Median: 22.67
vs GEHC: 25.32
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
GE HealthCare Technologies (NAS:GEHC) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
GE HealthCare Technologies's PE Ratio (TTM) for today is calculated as:
GE HealthCare Technologies's share price for today is $65.76.
GE HealthCare Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.180.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
GE HealthCare Technologies EV-to-FCF Related Terms
GE HealthCare Technologies EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, GE HealthCare Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GE HealthCare Technologies EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's EV-to-FCF falls into.
GE HealthCare Technologies's current Enterprise Value is $38,460 Mil.
GE HealthCare Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,519 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies (GEHC) has a EV-to-FCF of 25.32 as of Jun. 28, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on GE HealthCare Technologies and its competitors. This is near median its historical median of 26.73. Over the past decade, GE HealthCare Technologies' EV-to-FCF has ranged from 18.96 to 34.63. According to the industry distribution chart, GE HealthCare Technologies ranks #229 out of 419 companies in the Medical Devices & Instruments industry, placing it in the top 54.7%.
Is GE HealthCare Technologies' EV-to-FCF too high?
GE HealthCare Technologies' current EV-to-FCF of 25.32 is near median its 10-year median of 26.73. Over the past 10 years, this metric has ranged from a low of 18.96 to a high of 34.63. The Medical Devices & Instruments industry median EV-to-FCF is 22.67. GE HealthCare Technologies' value of 25.32 is 11.7% above this industry median. Based on the distribution chart, GE HealthCare Technologies ranks #229 out of 419 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, GE HealthCare Technologies has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' EV-to-FCF compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #229 out of 419 companies for EV-to-FCF. This places GE HealthCare Technologies in the lower half of its industry. The industry median EV-to-FCF is 22.67. GE HealthCare Technologies' value of 25.32 is 11.7% above this benchmark. Historically, GE HealthCare Technologies' own EV-to-FCF has ranged from 18.96 to 34.63 over the past decade. While the company's 10-year median is 26.73 vs. the industry median of 22.67, GE HealthCare Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.67, based on 419 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GE HealthCare Technologies's current EV-to-FCF of 25.32 is 11.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on GE HealthCare Technologies and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GE HealthCare Technologies's current EV-to-FCF is 25.32, which is near median its own 10-year median of 26.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is $85.04, compared to a current price of $65.76 — trading 22.7% below its estimated fair value. The current EV-to-FCF is 25.32, which is near median its 10-year median of 26.73 and 11.7% above the Medical Devices & Instruments industry median of 22.67. GE HealthCare Technologies' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For GE HealthCare Technologies (GEHC), the current EV-to-FCF is 25.32 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (GEHC) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of $65.76 is trading 22.7% below its estimated GF Value™ of $85.04.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for GEHC:
EV-to-FCF: 25.32 (near median its 10-year median of 26.73)
GF Value™: $85.04 vs. price of $65.76 (22.7% below fair value)
Industry Position: 11.7% above the Medical Devices & Instruments median (#229 of 419)
No single metric tells the full story. See the GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
72GF Score
Get the complete analysis for GEHC
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GEHC has been successfully added to your 
